홈MCP워크벤치Skills
홈워크벤치알림마이페이지
Huagongshe 오픈 프로젝트:[email protected]AI 접속: llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.7.8
  1. 홈
  2. /화합물

베릴륨디브로마이드

Beryllium bromide

HCID 82230
노트반응
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
7787-46-4
표준 SMILES
[Be+2].[Br-].[Br-]
InChIKey
PBKYCFJFZMEFRS-UHFFFAOYSA-L
분자식
BeBr2
평균 분자량
168.82 g/mol
단동위원소 질량
166.84886

개요

Beryllium bromide is a bromide of beryllium. Beryllium is a lightweight alkaline earth metal with the atomic number 4. It is a relatively rare element found naturally only combined with other elements in minerals. Bromine is a halogen element with the symbol Br and atomic number 35. Diatomic bromine does not occur naturally, but bromine salts can be found in crustal rock. (L625, L24)

이름 및 식별자

우선 이름
Beryllium bromide
IUPAC
beryllium dibromide
현지명
베릴륨디브로마이드
영어명
beryllium dibromide
분자식
BeBr2
분자량
168.820182

이름 및 동의어

Beryllium dibromideBeryllium bromideBeryllium bromide (BeBr2)UNII-T00751H2J8BEYLLIUM BROMIDEEINECS 232-115-9T00751H2J8BERYLLIUM BROMIDE [MI]DTXSID80999064dibromoberylliumRefChem:119108DTXCID301426040
이름 더 보기
베릴륨디브로마이드Beryllium bromide.beryllium(+2) cation dibromide
BeBr2UN15667787-46-4beryllium;dibromideSCHEMBL305807PBKYCFJFZMEFRS-UHFFFAOYSA-LDB-253972NS00080832

데이터베이스 식별자

CAS
7787-46-4
PubChem CID
82230
DTXSID
DTXSID80999064
UNII
T00751H2J8
EC Number
232-115-9
Nikkaji
J95.337G

물성

구조 계산 물성

극성 표면적
0 Ų
수소 결합 공여자 수
0
수소 결합 수용자 수
2
회전 가능 결합 수
0
무거운 원자 수
3
형식 전하
0
복잡도
0

실험 및 물리화학적 성질

Chemical ClassesMetals -> Beryllium Compounds, Inorganic
Physical DescriptionVery hygroscopic solid; [Merck Index] White odorless powder; [MSDSonline] White needles; [Ullmann]

물리화학적 성질

녹는점
506 · 506-509°; also reported as 488°
끓는 점
520 ° · bp 520°
밀도
3.465 · 3.465
용해도
2 O; · very soluble in H2O; soluble in ethanol, pyr
물리적 상태
사방정계 결정
색상
orthorhombic crystals, crystalline; hygroscopic
수용성
2 O · 매우 잘 녹는 H2O [MER06]
비열
0.41 J/ · Cp(crystal): 0.41 J/(g·K), at 25℃
EPA
Beryllium bromide (BeBr2) (7787-46-4)

화학적 성질

orthorhombic; very hygroscopic; -80 mesh, 99% purity; enthalpy of fusion 9.80 kJ/mol; made by reaction of Be and Br2 at 500°C–700°C [KIR78] [CER91] [MER06] [CRC10]

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

유해성 정보

Hazards SummaryAn irritant; May cause skin sensitization; Repeated or prolonged exposure may cause chronic beryllium disease; [MSDSonline] See Bromine. See Beryllium for one additional linked occupational disease.

안전 및 보호

Minimum Risk LevelChronic Oral: 0.002 mg/kg/day (Beryllium) (L134)
Threshold Limit Values (TLV)0.00005 [mg/m3], as Be, inhalable fraction
Permissible Exposure Limit (PEL)0.002 [mg/m3], as Be, Ceiling(OSHA) = 0.005 mg/m3, as Be(0.025 mg/m3,as Be,for 30 min.peak per 8-hr shift)
Immediately Dangerous to Life or Health (IDLH)4.0 [mg/m3], as Be

독성 정보

Treatment · 1건

EYES: irrigate opened eyes for several minutes under running water. INGESTION: do not induce vomiting. Rinse mouth with water (never give anything by mouth to an unconscious person). Seek immediate medical advice. SKIN: should be treated immediately by rinsing the affected parts in cold running water for at least 15 minutes, followed by thorough washing with soap and water. If necessary, the person should shower and change contaminated clothing and shoes, and then must seek medical attention. INHALATION: supply fresh air. If required provide artificial respiration.

Health Effects · 1건

Acute inhalation of a high level of beryllium can result in a pneumonia-like condition called acute beryllium disease. Chronic inhalation of beryllium can cause an inflammatory reaction in the respiratory system called chronic beryllium disease. Chronic beryllium disease may result in anorexia and weight loss, as well as right side heart enlargement and heart disease in advanced cases. Chronic exposure can also increase the risk of lung cancer. Skin contact with beryllium results in contact dermatitus. Bromine vapour causes irritation and direct damage to the mucous membranes. Elemental bromine also burns the skin. The bromide ion is a central nervous system depressant and chronic exposure produces neuronal effects. This is called bromism and can result in central reactions reaching from somnolence to coma, cachexia, exicosis, loss of reflexes or pathologic reflexes, clonic seizures, tremor, ataxia, loss of neural sensitivity, paresis, papillar edema of the eyes, abnormal speech, cerebral edema, delirium, aggressiveness, and psychoses. (L625, L626, L627, L24, L25)

화학 및 산업

약리 정보

Metabolism/Metabolites · 1건

Beryllium is absorbed mainly through the lungs, where it enters the bloodstream and is transported throughout the body by binding to prealbumins and gamma-globulins. Beryllium accumulates in lung tissue and the skeleton. It is excreted mainly in the urine. Bromine is mainly absorbed via inhalation, but may also enter the body through dermal contact. Bromine salts can be ingested. Due to its reactivity, bromine quickly forms bromide and may be deposited in the tissues, displacing other halogens. (L626, L25)

용도 및 제조

Uses · 2건

Used in organic synthesis; [Ullmann]

Beryllium foil is used in x-ray lithography for making integrated circuits. It is used as a reflector or moderator in nuclear reactions. Beryllium is used in gyroscopes and computer parts. Beryllium bromide has been used as a catalyst for the bromination of several organic molecules (L965, A595).

General Manufacturing InformationBeryllium bromide (BeBr2): INACTIVE
응용 분야 · 1건

용도Beryllium fluoride is used in biochemistry, particularly protein crystallography, since it binds in some of the same ways as phosphate does in human tissues. ADP and beryllium fluoride together tend to bind to ATP sites and inhibit protein action, making

제조 방법 · 1건

Beryllium bromide has the formula BeBr2. It is very hygroscopic and is soluble in water. It has the molecular weight of 168.821 g/mol. The structure has not been documented. Beryllium bromide can be prepared by reacting Be metal with elemental bromine at temperatures of 500°C–700°C: Be+Br2→BeBr2 Beryllium bromide is also formed when beryllium oxide with HBr in aqueous solution or hydrogen bromide in the gas phase: BeO+2HBr→BeBr2+H2O This bromide compound was first prepared by Wohler (1828) by the action of bromine vapor on the metal and also upon a mixture of carbon and beryllium oxide.Berthemot (1831) obtained it in solution by dissolving the oxide in hydrobromic acid. Humpridge (1883) also prepared it by acting on a mixture of the oxide and carbon with dry bromine. The anhydrous bromide is always obtained by sublimation as colorless white crystals.

관련 반응

0건
반응 기록 만들기

현재 필터 조건에 해당하는 반응 기록이 없습니다.

화합물 노트

불러오는 중…

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
Adverse EffectsFibrogenic - Inducing tissue injury and fibrosis (scarring).
Exposure RoutesOral (L626) ; inhalation (L626) ; dermal (L626)
Toxicity Summary · 1건

Once in the body, beryllium acts as a hapten and interacts with human leucocyte antigen (HLA) DP presenting cells in the lungs, becoming physically associated with a major histocompatability (MHC) class II molecule. This MHC class II-beryllium-peptide complex is recognized by the T lymphocyte receptor, triggering CD4+ T lymphocyte activation and proliferation. The resulting inflammatory response is a cell-mediated process orchestrated by cytokines and results in the formation of (usually pulmonary) granulomas. Beryllium's toxicity may be controlled by the iron-storage protein ferritin, which sequesters beryllium by binding it and preventing it from interacting with other enzymes. Bromine is a powerful oxidizing agent and is able to release oxygen free radicals from the water in mucous membranes. These free radicals are also potent oxidizers and produce tissue damage. In additon, the formation of hydrobromic and bromic acids will result in secondary irritation. The bromide ion is also known to affect the central nervous system, causing bromism. This is believed to be a result of bromide ions substituting for chloride ions in the in actions of neurotransmitters and transport systems, thus affecting numerous synaptic processes. (L626, L627, A543, L25, A37, A91)

Signs and Symptoms · 1건

Chronic beryllium disease causes fatigue, weakness, difficulty breathing, and a persistent dry cough. Bromine vapour causes irritation and direct damage to the mucous membranes. Symptoms include lacrimation, rhinorrhoea, eye irritation with mucous secretions from the oropharyngeal and upper airways, coughing, dyspnoea, choking, wheezing, epistaxis, and headache. The bromide ion is a central nervous system depressant producing ataxia, slurred speech, tremor, nausea, vomiting, lethargy, dizziness, visual disturbances, unsteadiness, headaches, impaired memory and concentration, disorientation and hallucinations. This is called bromism. (L626, L627, L24, L25)

Carcinogen Classification1, carcinogenic to humans. (L135)

안전 데이터

tsca
TSCA listed
ridadr
1566
포장분류
III
위험 등급
6.1(b)
기존화학 물질
KE-02832

공급사4 곳

Shaanxi Didu New Materials Co. Ltd+86-86-17392712779 +86-13289823923 · [email protected]
陕西缔都医药化工有限公司029-029-029-81148696 18161915376 · [email protected]
湖北玖天生物医药科技有限公司027-88013699 17354350817 · [email protected]
DAYANG CHEM (HANGZHOU) CO.,LTD+86-88938639 +86-17705817739 · [email protected]